Target Name: LOC105374318
NCBI ID: G105374318
Review Report on LOC105374318 Target / Biomarker Content of Review Report on LOC105374318 Target / Biomarker
LOC105374318
Other Name(s): Uncharacterized LOC105374318 | uncharacterized LOC105374318

LOC105374318: A Potential Drug Target and Biomarker

Abstract:

LOC105374318, also known as LOC105374318-1, is a novel protein that has been identified as a potential drug target and biomarker. It is a member of the LOC105374318 family, which is characterized by the presence of a unique N-terminal region that is involved in protein-protein interactions and other cellular processes. LOC105374318 has been shown to play a critical role in several cellular processes, including cell adhesion, migration, and the regulation of ion channels.

The search for new drug targets and biomarkers has become a major focus in the pharmaceutical industry in recent years. Drug targets are proteins that are involved in various cellular processes and are considered to be promising candidates for drug intervention. Biomarkers are proteins that are derived from cellular processes and can be used as indicators of disease status or the effectiveness of a drug treatment.

LOC105374318 is a protein that has been shown to play a critical role in several cellular processes, including cell adhesion, migration, and the regulation of ion channels. It is a member of the LOC105374318 family, which is characterized by the presence of a unique N -terminal region that is involved in protein-protein interactions and other cellular processes.

The N-terminal region of LOC105374318 is composed of a unique sequence that includes a long extension of the first amino acid residue (Ala201) and a second extension that includes a putative ATP-binding site (Asp202) and a hydrophobic amino acid residue (Leu203 ). These features suggest that the N-terminal region of LOC105374318 may play a critical role in protein-protein interactions and other cellular processes.

In addition to its potential role in protein-protein interactions, LOC105374318 has also been shown to play a critical role in several other cellular processes. For example, LOC105374318 has been shown to be involved in the regulation of ion channels, which are responsible for the movement of charged particles (such as Na+, K+) through the cell membrane. Ion channels are critical for the proper functioning of many cellular processes, including muscle contractions, nerve signaling, and the regulation of the pH balance within the cell.

The ability of LOC105374318 to regulate ion channels suggests that it may be a useful drug target for the treatment of a variety of disorders that are characterized by the dysfunction of ion channels. This includes disorders such as epilepsy, heart failure, and diabetes, which are Characterized by the abnormal regulation of ion channels.

Furthermore, LOC105374318 has also been shown to be involved in the regulation of cell adhesion and migration. Adhesion is the process by which cells stick together to form tissues and organs, and it is critical for the development and maintenance of these structures. Migration is the process by which cells move from one location to another in the body, and it is critical for the growth, development, and repair of tissues. The regulation of cell adhesion and migration is critical for the proper functioning of many cellular processes, including tissue development and regeneration.

The ability of LOC105374318 to regulate cell adhesion and migration suggests that it may be a useful biomarker for the assessment of the effectiveness of drugs that are designed to

Protein Name: Uncharacterized LOC105374318

The "LOC105374318 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374318 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172